Related Experiment Video
Updated: Jul 2, 2025

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
Published on: May 27, 2022
Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated
Chris Greene1, Ruairi Connolly2, Declan Brennan2
1Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Insights
Blood-brain barrier disruption occurs in COVID-19 and long COVID brain fog. This involves systemic inflammation and impaired immune responses, contributing to cognitive impairment.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Coronavirus disease 2019 (COVID-19) pathogenesis involves vascular disruption.
- Neurological sequelae of long COVID are common, but blood-brain barrier (BBB) function in these conditions is not well understood.
Purpose of the Study:
- To investigate the impact of COVID-19 and long COVID on blood-brain barrier (BBB) integrity.
- To identify the mechanisms underlying cognitive impairment (brain fog) in long COVID.
Main Methods:
- Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to assess BBB permeability.
- Transcriptomic analysis of peripheral blood mononuclear cells (PBMCs).
- In vitro assays examining PBMC adhesion to brain endothelial cells and endothelial cell responses to patient serum.
Main Results:
- Evidence of BBB disruption in acute COVID-19 and in long COVID patients with brain fog.
- Transcriptomic analysis revealed coagulation system dysregulation and a weakened adaptive immune response in individuals with brain fog.
- Increased PBMC adhesion to brain endothelial cells and inflammatory marker expression in endothelial cells exposed to long COVID serum.
Conclusions:
- Sustained systemic inflammation and localized BBB dysfunction are key features of long COVID-associated brain fog.
- These findings highlight the role of vascular and immune dysregulation in long COVID neurological symptoms.
Abstract:
Vascular disruption has been implicated in coronavirus disease 2019 (COVID-19) pathogenesis and may predispose to the neurological sequelae associated with long COVID, yet it is unclear how blood-brain barrier (BBB) function is affected in these conditions. Here we show that BBB disruption is evident during acute infection and in patients with long COVID with cognitive impairment, commonly referred to as brain fog. Using dynamic contrast-enhanced magnetic resonance imaging, we show BBB disruption in patients with long COVID-associated brain fog. Transcriptomic analysis of peripheral blood mononuclear cells revealed dysregulation of the coagulation system and a dampened adaptive immune response in individuals with brain fog. Accordingly, peripheral blood mononuclear cells showed increased adhesion to human brain endothelial cells in vitro, while exposure of brain endothelial cells to serum from patients with long COVID induced expression of inflammatory markers. Together, our data suggest that sustained systemic inflammation and persistent localized BBB dysfunction is a key feature of long COVID-associated brain fog.
More Related Videos
Related Concept Videos
The Blood-brain Barrier
Long-term Depression
Calcium Ion Concentration Mechanism
If over...

